Stocks Had Their Best Month In 33 Years, But Here’s Why Experts Are Skeptical

  • 📰 Forbes
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 53%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

There are reasons to doubt the stock market’s latest rally, experts say.

Of the 275 companies in the S&P 500 that have reported earnings so far, only 67% have beat expectations while almost 29% have missed , according to Refinitiv.

But some experts are still hopeful: “The market is clearly looking beyond the current quarter,” and while a lot of bad news has come out, “none of this was a surprise,” says Chris Marangi, co-chief investment officer at Gamco. “I have more confidence in the rally today than I would have before we got incremental data from a lot of companies during earnings season,” he says.The coronavirus market sell-off, which began February 19th through to the low on March 23, was the fastest drop of more than 30% on record for the S&P 500. Then, markets rallied through April, making it the shortest bear market on record at just 33 days.

in a recent note. With the “dual benefits of record monetary and fiscal stimulus helping to bridge those most impacted by COVID-19,” the firm expects “a much stronger economy later in 2020.”

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.

Current NEEDs like food and clothes next tourism

$TSLA Sue Elon Musk & make him pay fine equivalent to market cap drop from the tweet time to low of the day. Irresponsible idiots tweeting with impunity should be arrested and prosecuted for manipulation of stocks, people minds, for causing wild gyrations in stock market. Tesla

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 394. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

Stocks head for best month on record ahead of ECBWorld stocks headed for their best month on record on Thursday, as encouraging early results from a COVID-19 treatment trial and expectations of more European Central Bank (ECB) stimulus later in the day helped ease the pain of February and March. 'That being said, about 25% of patients receiving it have severe side effects, including multiple-organ dysfunction syndrome, septic shock, acute kidney injury and low blood pressure. Another 23% demonstrated evidence of liver damage on lab tests' Why is this drug being promoted? We are in a Global Recession. Possibly Depression. Positive vibes from Canada 🇨🇦
Källa: Reuters - 🏆 2. / 97 Läs mer »

Stocks rally on treatment hopes, currencies await ECBAsian stocks rose to a fresh seven-week high on Thursday, lifted by encouraging early results from a COVID-19 treatment trial, though bonds and currencies held cautious ranges ahead of a European Central Bank meeting later in the day. FUNNY COFFIN DANCE MEME | Funeral Dance Meme | astronomia memes SPLENDORDIARY: FUNNY COFFIN DANCE MEME | Funeral Dance Meme | astronomia memes
Källa: Reuters - 🏆 2. / 97 Läs mer »

Asian stocks set to track U.S. gains as virus treatment hopes lift confidenceAsian equity markets were poised to gain on Thursday, tracking Wall Street's rally after positive trial results of an experimental COVID-19 treatment, a U.S. Federal Reserve pledge to shore up the economy and a jump in oil prices. boycottChineseProducts Ahhh dirtychina managed to take over a pharmaceutical company that doea remesidivir? Srole the IP now magically WHO will say its.the cure boycottchina makechinapay punishchina
Källa: Reuters - 🏆 2. / 97 Läs mer »

Asia stocks set to rise on hopes of coronavirus treatment; China's manufacturing data aheadStocks in Asia were set to rise at the open on Thursday following positive developments overnight on a potential new treatment for Covid-19. *manufactured data Shouldn’t be allowed to have it.. it doesn’t work fook off
Källa: CNBC - 🏆 12. / 72 Läs mer »